LARIMAR THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.32 USD | +2.81% |
|
-11.17% | +60.88% |
| May. 09 | Larimar Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| May. 09 | Zafgen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Bio Therapeutic Drugs | +2.81% | -11.17% | +60.88% | +44.66% | - | 454M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- LRMR Stock
- Charts Larimar Therapeutics, Inc.
- Comparison Chart